Legal Representation
Attorney
Cynthia J. Walden
USPTO Deadlines 3 active 3 overdue
| Deadline Type | Event Code | Deadline Date | Days Until | Priority | Extension Available |
|---|---|---|---|---|---|
|
EXAMINER AMENDMENT
Examiner's Amendment Completed |
CNEA | Dec 27, 2022 | 923 days overdue | Low | No |
|
OPPOSITION
Notice of Publication |
NPUB | Feb 16, 2023 | 872 days overdue | Medium | Until Mar 16, 2023 |
|
ITU SOU
Notice of Allowance Mailed - SOU Required |
NOAM | Sep 14, 2023 | 662 days overdue | High | Until Mar 14, 2024 |
Application History
31 events| Date | Code | Type | Description |
|---|---|---|---|
| Mar 12, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Mar 12, 2025 | EX4G | S | SOU EXTENSION 4 GRANTED |
| Mar 11, 2025 | EXT4 | S | SOU EXTENSION 4 FILED |
| Mar 11, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Sep 6, 2024 | EXT3 | S | SOU EXTENSION 3 FILED |
| Sep 6, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Sep 6, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Sep 6, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Mar 15, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Mar 14, 2024 | EXT2 | S | SOU EXTENSION 2 FILED |
| Mar 14, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Mar 14, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Sep 15, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Sep 13, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Sep 13, 2023 | EXT1 | S | SOU EXTENSION 1 FILED |
| Sep 13, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Mar 14, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Jan 17, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jan 17, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Dec 28, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Dec 12, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Dec 12, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Dec 12, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Dec 12, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
| Dec 12, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Jun 23, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Jun 23, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Jun 23, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Jun 21, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
| Oct 22, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sep 21, 2021 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 001
proteins for use in the manufacture of immunotherapeutics; reagents for research purposes
Class 005
pharmaceutical preparations for the treatment of age-related and inflammatory diseases and disorders
Classification
International Classes
001
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOLOGICS"